Deadline is Fast Approaching on Sunday, December 1st, 2024, at 11:59 p.m. ET Shareholders Should Call Their Brokers Today to Ensure […]

WAYNE, Pa., Nov. 18, 2024 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) (the “Company” or “Aclaris”), a clinical-stage biopharmaceutical […]

– Enhances Aclaris’ pipeline with complementary biologics portfolio –– Expands leadership team with addition of seasoned biotech executives –– Management […]

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. Amounts in CAD unless otherwise noted […]

RIMOUSKI, Québec, Nov. 18, 2024 (GLOBE NEWSWIRE) — Puma Exploration Inc. (TSXV: PUMA, OTCQB: PUMXF) (the “Company” or “Puma”) is […]

VANCOUVER, Canada, Nov. 18, 2024 (GLOBE NEWSWIRE) — Sonoro Gold Corp. (TSXV: SGO | OTCQB: SMOFF | FRA: 23SP) (“Sonoro” […]

Key UAV stakeholders assembled with government officials to confer on U.S. drone technology matters  WICHITA, Kan., Nov. 18, 2024 (GLOBE […]

SAN DIEGO, Nov. 18, 2024 (GLOBE NEWSWIRE) — Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing […]